Early assessment of minimal residual disease in AML by flow cytometry during aplasia identifies patients at increased risk of relapse.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Eva Hoster |
| Publication date | June 10, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |